Join our email list to stay up to date on the latest Amyloidosis news.

Join us for an engaging webinar with Kristen Hsu, ARC’s Executive Director of Research, as she shares the latest updates on ATTR (transthyretin amyloidosis) clinical trials — and what these developments mean for patients and families.

The webinar concludes with a Q and A session.

 

Was the information on this page helpful?
YesNo
*
*
*








*